Based on mRNA expression levels [42], the CAPZA1/B2 heterodimer is more prominently expressed than the CAPZA2/B2 in the PC-3 prostate cancer cells, which were used in most of our cellular assays. Here, CAPZA1 is linked to prostate cancer.